MAPT and Alzheimer disease: Analyzing cerebrospinal fluid (CSF) levels of amyloid-β peptide of 42 amino acids (Aβ1–42), total tau protein (T-tau) and tau phosphorylated at threonine 181 (P-tau181P) increases diagnostic certainty for AD (3).